
Dimpride 5mg Tablet
Marketer
Alkem Laboratories Ltd
Salt Composition
Dapagliflozin (5mg)
Overview Dimpride 5mg Tablet
Glucoprime 5mg tablets are indicated as monotherapy or adjunctive therapy in managing type 2 diabetes. This medication assists in regulating elevated blood glucose, mitigating the risk of severe diabetic complications and potentially cardiovascular events. Glucoprime 5mg can be administered with or without food, ideally at the same time daily, as prescribed by your physician. Discontinuation requires medical consultation; otherwise, hyperglycemia and subsequent complications such as renal impairment and vision loss may occur. This treatment forms part of a comprehensive program encompassing a balanced diet, physical activity, and weight management, all under medical supervision. Common adverse reactions include vaginal candidiasis, rhinopharyngitis, and urinary tract infections; diuresis may also be observed, necessitating increased fluid intake to avoid dehydration. Practicing good hygiene is crucial to reducing the risk of genital fungal infections. Prior to commencing treatment, disclose any pre-existing renal or hepatic dysfunction, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical advice before use. Limit alcohol consumption during therapy to minimize the potential for adverse effects. Regular blood glucose monitoring is essential throughout treatment.
Primary Ingredients of Dimpride 5mg Tablet
No information provided. Unable to rephrase.
Uses of Dimpride 5mg Tablet
Managing type 2 diabetes
Major Benefits of Dimpride 5mg Tablet:
Consume this medication according to your physician's prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dimpride 5mg Tablets can be administered with or without food, however, consistent daily timing is recommended.
Common Side effects of Dimpride 5mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dimpride 5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dimpride 5mg Tablets can be administered with or without food, although consistent timing is recommended.
How Dimpride 5mg Tablet works:
Glyburide 5mg tablets help manage diabetes by promoting the excretion of excess glucose via the kidneys.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Dimpride 5mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dimpride 5mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Using Dimpride 5mg tablets while breastfeeding is likely inadvisable. Preliminary research indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Dimpride 5mg Tablets due to potential safety concerns. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Dimpride 5mg tablets are considered safe for use by individuals with hepatic impairment. No alteration to the Dimpride 5mg tablet dosage is necessary.
What if you forget to take Dimpride 5mg Tablet :
Should you forget a Dimpride 5mg Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dimpride 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
| Action Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
